Skip to main content
United States
Jump To
Support
Register or Log In
Support
Register or Log In
Instructors
Browse Products
Getting Started
Students
Browse Products
Getting Started
Return to Genomics Student Resources
Chapter 1 Online quizzes
Rare Diseases: A Genomics Perspective
Quiz Content
*
not completed
In Europe, a rare disease is currently classed as one that affects:
Fewer than 1 in 100 individuals
correct
incorrect
Fewer than 1 in 1,000 individuals
correct
incorrect
Fewer than 1 in 2,000 individuals
correct
incorrect
Fewer than 1 in 10,000 individuals
correct
incorrect
*
not completed
When was the Human Genome published?
1998
correct
incorrect
2000
correct
incorrect
2002
correct
incorrect
2001
correct
incorrect
*
not completed
What is a population bottleneck?
An event or series of events that dramatically reduce the size of a population
correct
incorrect
A disease that kills a large part of the population
correct
incorrect
An evolutionary mechanism where new alleles are introduced to the population
correct
incorrect
A reduction in population size caused by rare disease
correct
incorrect
*
not completed
What was the cause of Tamika and Caitlyn's rare disease?
A mutation inherited from a parent.
correct
incorrect
A de novo mutation in the same gene in both girls
correct
incorrect
We still don't know
correct
incorrect
A de novo mutation in a different gene in each girl
correct
incorrect
*
not completed
Approximately how many children does the DDD study estimate are born with a rare disease globally each year?
10,000
correct
incorrect
90,000
correct
incorrect
250,000
correct
incorrect
400,000
correct
incorrect
*
not completed
What is an HPO term?
A set of medically standardized terms to describe phenotypic abnormalities
correct
incorrect
A diagnostic tool used by clinicians to diagnose patients
correct
incorrect
An online database of genetic disorders
correct
incorrect
A list of characteristics to describe a particular disorder
correct
incorrect
*
not completed
What is the purpose of the ExAC Consortium?
To share data collected by clinicians on rare disease
correct
incorrect
To sequence the exomes of patients with rare disease
correct
incorrect
To find the cause of rare disease
correct
incorrect
To provide standardized and open source database of exome and whole genome sequencing data from around the world
correct
incorrect
*
not completed
Why does Decipher have two levels of access to its data (public and controlled)?
To protect the anonymity of the patients whose data is uploaded to the database
correct
incorrect
To make sure clinicians can keep their diagnoses private
correct
incorrect
To stop the database from becoming overloaded
correct
incorrect
To stop the website being hacked
correct
incorrect
*
not completed
What mechanism is thought to cause Wiedermannsteiner Syndrome?
Inherited mutations interacting with each other in KMT2A/MLL
correct
incorrect
We still don't know
correct
incorrect
De novo mutations that prematurely truncate the protein product in KMT2A/MLL
correct
incorrect
De novo mutations in the noncoding and regulatory parts of the KMT2A gene
correct
incorrect
*
not completed
Why is gene therapy trialled in animals before humans?
At the moment technical challenges make it difficult to trial safely in humans
correct
incorrect
Animals have similar physiology and biology to humans
correct
incorrect
Animals suffer some of the same diseases as humans
correct
incorrect
Animals have a shorter lifespan than humans
correct
incorrect
Previous Question
Submit Quiz
Next Question
Reset
Exit Quiz
Review & Submit
Submit Quiz
Are you sure?
You have some unanswered questions. Do you really want to submit?
Back to top
Printed from , all rights reserved. © Oxford University Press, 2024
Select your Country